Immitra Bio

€2.6M pre-seed

Announced: Jul 22, 2026
Sector: genetic medicine
Investors: 9

Summary

Immitra Bio completed an upsized €2.58 million pre-seed financing round to advance its in-vivo genetic medicine platform. The capital will support preclinical proof-of-concept studies for its lead candidate and further platform development.

Investors

Backbone Ventures, OCCIDENT, Another VC, Kickfund, Venture Kick, Zürcher Kantonalbank, FONGIT, ETH Foundation, select private investors